Initiation of SeHCAT® protocol in a digestive service: a further step in the management of chronic diarrhea
Maria Martinez Burgos1, Javier Villena-Salinas2, José Antonio Martínez Otón3
1Aparato Digestivo, Hospital Universitario Santa Lucía , España.
Abstract:
Bile acid malabsorption (BAM) is a common cause of chronic diarrhoea. Recent work has shown that it is probably an under-diagnosed entity. BAM is classified into 4 types depending on what conditions it. Type I involves organic involvement of the ileal mucosa. Type II is related to alterations in permeability in what is known as irritable bowel syndrome with a predominance of diarrhoea. Type III is related to other alterations of the digestive tract such as celiac disease, pancreatic insufficiency, cholecystectomy or bacterial overgrowth. Type IV is related to drugs that produce MAB as a side effect. There is a test for the detection of MAB with high sensitivity and specificity, non-invasive and with few associated complications, which is the 75Selenium and tauroselcholic acid scintigraphy (75SeHCAT®).
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Constipation-Predominant IBS


